1) Clinical benefit response
临床受益反应
1.
The curative effect was estimated according to the standard of WHO and the clinical benefit response was evaluated at the same time.
目的 :观察吉西他滨 (GEM)、氟尿嘧啶 (5 FU)及顺铂 (DDP)三药联合化疗对晚期胰腺癌的客观疗效及其临床受益反应 (CBR)。
2) Clinical benifit rate
临床受益反应率
3) clinical benefit
临床受益
1.
The clinical benefit of CPT-11 combined with 5-FU/CF for patients with locally advanced or metastatic colorectal cancer;
伊立替康联合5-Fu/CF治疗晚期结直肠癌的临床受益分析
4) the clinical benefit curative effect
临床受益疗效
5) sub-clinical rejection
亚临床排斥反应
1.
Objective To observe the expression of interleukin (IL)-2、IL-6、IL-8 and IL-10, the changes of other immunological parameters and their mutual relations in patients with the sub-clinical rejection after renal transplantation, and to explore the application of cytokines in patients after renal transplantation during follow-up.
目的 观察肾移植术后亚临床排斥反应患者血清中白细胞介素(IL)-2、IL-6、IL-8、IL-10水平变化和其它免疫学指标的变化及相互关系,以探讨细胞因子在肾移植术后随访中的应用价值。
6) clinical allergology
变态反应临床学
补充资料：(税收的)受益原则
(税收的)受益原则：认为税收与人们从政府活动中的受益应当成比例的原则。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条